Belhaven Biopharma Inc. research brief
CIK 1873965
Generated Nov. 18, 2026, 3 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: Chapel Hill North Carolina. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 15, 2025 · D · 0001231919-25-000318 · Source evidence
Reported offering amount: 32289627 USD. Reported amount sold: 32289627 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Belhaven Biopharma Inc. research brief,” CIK 1873965, retrieved Nov. 18, 2026, 3 a.m.. Cite the specific accessions used. No amounts have been summed.